Search

Your search keyword '"Docetaxel -- Research"' showing total 513 results
Start Over Descriptor "Docetaxel -- Research"
513 results on '"Docetaxel -- Research"'

501. Research on docetaxel therapy reported by R.A.B. Vanwaterschoot et al

Subjects
Docetaxel -- Research, Cancer -- Care and treatment, Business, Health, Health care industry
Abstract

According to recent research from Netherlands, 'Docetaxel is one of the most widely used anticancer drugs. A major problem with docetaxel treatment, however, is the considerable interpatient variability in docetaxel [...]

Published
2010

502. Reports outline bioengineering study findings from C. Zhang and colleagues

Subjects
Drugs -- Research, Docetaxel -- Research, Cancer -- Care and treatment, DNA, Phosphotransferases, Cell research
Abstract

According to recent research from the United States, "Checkpoint kinase 1 (Chk1) plays a critical role in the activation of mitotic spindle checkpoint and DNA damage checkpoint. We examined the [...]

Published
2009

503. Study results from N. Yoshimura et al provide new insights into non-small cell lung cancer

Subjects
Communicable diseases -- Research, Communicable diseases -- Care and treatment, Drugs -- Research, Respiratory tract infections -- Research, Respiratory tract infections -- Care and treatment, Docetaxel -- Research, Lung cancer, Non-small cell -- Research, Lung cancer, Non-small cell -- Care and treatment, Cancer -- Research, Oncology, Experimental, Cell research
Abstract

According to recent research from Osaka, Japan, "Mainly single-agent chemotherapy has been considered as standard treatment for elderly patients with non-small cell lung cancer (NSCLC). Docetaxel monotherapy is regarded as [...]

Published
2009

504. Uppsala University details research in head and neck cancer

Subjects
Uppsala University, Drugs -- Research, Tumor proteins -- Research, Tumor proteins -- Care and treatment, Docetaxel -- Research, Head and neck cancer -- Research, Head and neck cancer -- Care and treatment, Cancer -- Research, Cancer -- Care and treatment, Oncology, Experimental, Universities and colleges, Radiotherapy
Abstract

"Radiotherapy is the most frequently used and cheapest treatment both for curative and palliative purposes in HNSCC. Despite advances in technology and intensive treatments with radiation, only half of the [...]

Published
2009

505. New prostate cancer research from University of Florida discussed

Subjects
University of Florida -- Reports, Radiotherapy -- Reports, Oncology, Experimental -- Reports, Metastasis -- Research, Metastasis -- Reports, Prostate cancer -- Research, Prostate cancer -- Reports, Docetaxel -- Research, Docetaxel -- Reports, Universities and colleges -- Reports, Drugs -- Research, Drugs -- Reports, Cancer -- Research, Cancer -- Reports, Cancer -- Care and treatment, Cancer -- Genetic aspects
Abstract

" Currently, docetaxel is used to treat hormone-refractory metastatic prostate cancer. Docetaxel not only inhibits microtubule formation but can also downregulate expression of Bcl-2, a known antiapoptotic oncogene," scientists writing [...]

Published
2008

506. New lung cancer study findings reported from Dublin City University

Subjects
Taxol (Medication), Docetaxel -- Research, Lung cancer -- Research, Communicable diseases -- Research, Drugs -- Research, Cancer -- Care and treatment, Cancer -- Research, Tubulins, Universities and colleges, Oncology, Experimental
Abstract

"Pulse selections on a chemotherapy naive squamous lung carcinoma cell line, SKMES-1, with clinically relevant concentrations of taxanes (taxol or taxotere) resulted in the development of a stable taxotere-resistant variant, [...]

Published
2008

508. New findings from B. Vincenzi and co-researchers in the area of cancer therapy described

Subjects
Docetaxel -- Research, Cancer -- Care and treatment, Drugs -- Research, Cancer -- Research, Oncology, Experimental
Abstract

Current study results from the report, 'Docetaxel induced pericardial effusion,' have been published (see also Cancer Therapy). "Docetaxel is a complex diterpene obtained from Taxus Brevifolia, and it is one [...]

Published
2007

509. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer

Subjects
Oncology, Experimental -- Reports, Clinical trials -- Reports, Prednisone -- Research, Prednisone -- Reports, Metastasis -- Research, Metastasis -- Care and treatment, Metastasis -- Reports, Corticosteroids -- Research, Corticosteroids -- Reports, Docetaxel -- Research, Docetaxel -- Reports, Cancer -- Research, Cancer -- Reports
Abstract

Taxotere(R) (docetaxel) Injection Concentrate-based chemotherapy (Taxotere plus prednisone) maintained long-term efficacy as a treatment for advanced (metastatic) hormone-resistant prostate cancer patients, according to the three-year updated results of the landmark [...]

Published
2007

510. Reports on angiogenesis findings from Johns Hopkins University, Sidney Kimmel Cancer Center provide new insights

Subjects
Cancer -- Care and treatment, Cancer -- Reports, Metastasis -- Research, Metastasis -- Reports, Prostate cancer -- Research, Prostate cancer -- Reports, Docetaxel -- Research, Docetaxel -- Reports, Quinoline -- Reports, Universities and colleges -- Reports, Oncology, Experimental -- Reports, Cancer -- Research
Abstract

Research findings, "The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts," are discussed in a new [...]

Published
2007

511. Recent findings from Montefiore Medical Center, Bronx, U.S., illuminate medical research

Subjects
Montefiore Medical Center (New York, New York), Coronary heart disease -- Research, Docetaxel -- Research, Heat shock proteins, Endothelial growth factors, Medical centers, Hospitals, Medical research, Medicine, Experimental
Abstract

Recent findings from Montefiore Medical Center, Bronx, U.S., illuminate medical research. This trend article about Montefiore Medical Center, Bronx, U.S., is an immediate alert from NewsRx to identify developing directions [...]

Published
2006

512. Data presented on cetuximab combined with docetaxel

Subjects
ImClone Systems Inc. -- Research, Bristol-Myers Squibb Co. -- Research, Erbitux (Medication) -- Research, Biological products industry -- Research, Docetaxel -- Research
Abstract

2002 JUN 11 - (NewsRx.com & NewsRx.net) -- ImClone Systems Inc. (IMCL) and Bristol-Myers Squibb (BMY) announced data from a study of the investigational monoclonal antibody Erbitux (cetuximab) in combination [...]

Published
2002

513. A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma

Subjects
Docetaxel -- Research, Pathology, Gynecological -- Research, Health care industry -- Research, Health care industry, Health
Abstract

ABSTRACT & COMMENTARY Synopsis: Docetaxel is active in paclitaxel-resistant ovarian and peritoneal cancer, but, in view of significant hematologic toxicity, further study is warranted to ascertain its optimal dose and [...]

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results